Product
Assigned Interventions
1 clinical trial
3 indications
Indication
Lung TransplantationIndication
Chronic Lung Transplant RejectionIndication
ImmunodeficiencyClinical trial
A Randomized, Open-label,Controlled Phase II b Study to Demonstrate Efficacy and Safety of Sirolimus Chronic Rejection After Lung TransplantStatus: Withdrawn, Estimated PCD: 2024-06-30